377 related articles for article (PubMed ID: 23768735)
1. A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease.
Donath E; Chaudhry A; Hernandez-Aya LF; Lit L
Respir Med; 2013 Sep; 107(9):1385-92. PubMed ID: 23768735
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Herath SC; Poole P
Cochrane Database Syst Rev; 2013 Nov; (11):CD009764. PubMed ID: 24288145
[TBL] [Abstract][Full Text] [Related]
4. Macrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysis.
Yao GY; Ma YL; Zhang MQ; Gao ZC
Respiration; 2013; 86(3):254-60. PubMed ID: 23817204
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis.
Ni W; Shao X; Cai X; Wei C; Cui J; Wang R; Liu Y
PLoS One; 2015; 10(3):e0121257. PubMed ID: 25812085
[TBL] [Abstract][Full Text] [Related]
6. Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations.
Seemungal TA; Wilkinson TM; Hurst JR; Perera WR; Sapsford RJ; Wedzicha JA
Am J Respir Crit Care Med; 2008 Dec; 178(11):1139-47. PubMed ID: 18723437
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term macrolide therapy at low doses in stable COPD.
Cao Y; Xuan S; Wu Y; Yao X
Int J Chron Obstruct Pulmon Dis; 2019; 14():1289-1298. PubMed ID: 31354258
[No Abstract] [Full Text] [Related]
8. Systematic review and meta-analysis of prophylactic antibiotics in COPD and/or chronic bronchitis.
Lee JS; Park DA; Hong Y; Jo KW; Lee SW; Huh JW; Oh YM; Lee SD
Int J Tuberc Lung Dis; 2013 Feb; 17(2):153-62. PubMed ID: 23317949
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trial.
Uzun S; Djamin RS; Kluytmans JA; Mulder PG; van't Veer NE; Ermens AA; Pelle AJ; Hoogsteden HC; Aerts JG; van der Eerden MM
Lancet Respir Med; 2014 May; 2(5):361-8. PubMed ID: 24746000
[TBL] [Abstract][Full Text] [Related]
10. Are prophylactic antibiotics useful in chronic obstructive pulmonary disease?
Arenas A; Rada G
Medwave; 2015 Nov; 15 Suppl 3():e6309. PubMed ID: 26571418
[TBL] [Abstract][Full Text] [Related]
11. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
12. Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
Simoens S; Laekeman G; Decramer M
Respir Med; 2013 May; 107(5):637-48. PubMed ID: 23352223
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Ram FS; Rodriguez-Roisin R; Granados-Navarrete A; Garcia-Aymerich J; Barnes NC
Cochrane Database Syst Rev; 2006 Apr; (2):CD004403. PubMed ID: 16625602
[TBL] [Abstract][Full Text] [Related]
14. Antibiotics for treatment and prevention of exacerbations of chronic obstructive pulmonary disease.
Wilson R; Sethi S; Anzueto A; Miravitlles M
J Infect; 2013 Dec; 67(6):497-515. PubMed ID: 23973659
[TBL] [Abstract][Full Text] [Related]
15. Macrolide effects on the prevention of COPD exacerbations.
Yamaya M; Azuma A; Takizawa H; Kadota J; Tamaoki J; Kudoh S
Eur Respir J; 2012 Aug; 40(2):485-94. PubMed ID: 22408201
[TBL] [Abstract][Full Text] [Related]
16. Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials.
Wang Y; Zijp TR; Bahar MA; Kocks JWH; Wilffert B; Hak E
J Antimicrob Chemother; 2018 Dec; 73(12):3231-3243. PubMed ID: 30189002
[TBL] [Abstract][Full Text] [Related]
17. Antibiotics as immunomodulant agents in COPD.
Blasi F; Mantero M; Aliberti S
Curr Opin Pharmacol; 2012 Jun; 12(3):293-9. PubMed ID: 22321568
[TBL] [Abstract][Full Text] [Related]
18. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
[TBL] [Abstract][Full Text] [Related]
19. [Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)].
Burgel PR
Med Mal Infect; 2006; 36(11-12):706-17. PubMed ID: 16839731
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of macrolides and quinolones for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).
Rothberg MB; Pekow PS; Lahti M; Brody O; Skiest DJ; Lindenauer PK
J Hosp Med; 2010; 5(5):261-7. PubMed ID: 20533570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
